Literature DB >> 2227129

Contribution of impaired muscle glucose clearance to reduced postabsorptive systemic glucose clearance in NIDDM.

J E Gerich1, A Mitrakou, D Kelley, L Mandarino, N Nurjhan, J Reilly, T Jenssen, T Veneman, A Consoli.   

Abstract

The reduced postabsorptive rates of systemic glucose clearance in non-insulin-dependent diabetes mellitus (NIDDM) are thought to be the consequence of insulin resistance in peripheral tissues. Although the peripheral tissues involved have not been identified, it is generally assumed to be primarily muscle, the major site of insulin-mediated glucose disposal. To test this hypothesis, we measured postabsorptive systemic and forearm glucose utilization and clearance in 15 volunteers with NIDDM and 15 age- and weight-matched nondiabetic volunteers. Although systemic glucose utilization was increased in NIDDM subjects (14.5 +/- 0.5 vs. 11.2 +/- 0.2 mumol.kg-1.min-1, P less than 0.001), systemic glucose clearance was reduced 1.40 +/- 0.06 vs. 2.13 +/- 0.05 ml.kg-1.min-1, P less than 0.01). Although forearm glucose utilization was increased in NIDDM subjects (0.663 +/- 0.058 vs. 0.411 +/- 0.019 mumol.dl-1.min-1, P less than 0.001), forearm glucose dl-1 clearance was reduced (0.628 +/- 0.044 vs. 0.774 +/- 0.037 ml.L-1.min-1, P less than 0.01). However, extrapolation of forearm data to total-body muscle indicated that impaired clearance reduced muscle glucose disposal by only 61 +/- 21 mumol/min, whereas impaired systemic clearance reduced systemic glucose disposal by 662 +/- 82 mumol/min. Thus, impaired muscle glucose clearance accounted for less than 10% of the reduced systemic glucose clearance in NIDDM subjects. Therefore, we conclude that muscle insulin resistance plays only a minor role in the reduced systemic glucose clearance found in NIDDM in the postabsorptive state and propose that reduced brain glucose clearance is largely responsible.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227129     DOI: 10.2337/diab.39.2.211

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

Review 1.  Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

2.  Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus.

Authors:  T Utriainen; P Nuutila; T Takala; P Vicini; U Ruotsalainen; T Rönnemaa; T Tolvanen; M Raitakari; M Haaparanta; O Kirvelä; C Cobelli; H Yki-Järvinen
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 3.  Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus?

Authors:  J E Gerich
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

4.  Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism.

Authors:  A Consoli; N Nurjhan; J J Reilly; D M Bier; J E Gerich
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 5.  Acute and chronic effects of hyperglycaemia on glucose metabolism.

Authors:  H Yki-Järvinen
Journal:  Diabetologia       Date:  1990-10       Impact factor: 10.122

6.  Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.

Authors:  H Yki-Järvinen; R Kauppinen-Mäkelin; M Tiikkainen; M Vähätalo; H Virtamo; K Nikkilä; T Tulokas; S Hulme; K Hardy; S McNulty; J Hänninen; H Levänen; S Lahdenperä; R Lehtonen; L Ryysy
Journal:  Diabetologia       Date:  2006-02-03       Impact factor: 10.122

Review 7.  Emerging treatments for post-transplantation diabetes mellitus.

Authors:  Trond Jenssen; Anders Hartmann
Journal:  Nat Rev Nephrol       Date:  2015-04-28       Impact factor: 28.314

Review 8.  Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle.

Authors:  H U Häring; H Mehnert
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

9.  Effect of cigarette smoking and of a transdermal nicotine delivery system on glucoregulation in type 2 diabetes mellitus.

Authors:  L Epifano; A Di Vincenzo; C Fanelli; F Porcellati; G Perriello; P De Feo; M Motolese; P Brunetti; G B Bolli
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

10.  Basal glucose turnover in Psammomys obesus. An animal model of type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  R C Habito; M Barnett; A Yamamoto; D Cameron-Smith; K O'Dea; P Zimmet; G R Collier
Journal:  Acta Diabetol       Date:  1995-10       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.